Are fucoidan and alginate active substances affecting CYP7A1 and HMG CoA reductase in dyslipidemia condition?
Context: Dyslipidemia, characterized by abnormal plasma lipid levels, is commonly treated with statins, which may induce adverse effects. Fucoidan and alginate, bioactive marine polysaccharides, have emerged as potential natural modulators of lipid metabolism via cholesterol 7 alpha-hydroxylase 1 (C...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
GarVal Editorial Ltda.
2026-01-01
|
| シリーズ: | Journal of Pharmacy & Pharmacognosy Research |
| 主題: | |
| オンライン･アクセス: | https://jppres.com/jppres/pdf/vol14/jppres_14.1.2388.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|